Overview
The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Cataract surgery with precedent bilateral randomized IOL implantation will be performed in subjects who have signed an informed consent form. Postoperative examinations will be implemented in accordance with the approved investigational plan.
Eligibility
Inclusion Criteria:
- Bilateral age-related cataract planned for phacoemulsification extraction and posterior IOL implantation
- Age 50 to 100
- Visual potential in both eyes of 20/25 or better as determined by investigators estimation
- Normal findings in medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
Exclusion Criteria:
- Preceding intraocular surgery or ocular trauma
- Relevant other ophthalmic diseases that particularly effects the zonular apparatus (such as severe pseudoexfoliation syndrome, preceding cryocoagulation, trauma)
- Pupil diameter < 2.0 mm (photopic)
- Laser treatment
- Uncontrolled systemic or ocular disease
- Pregnancy/Nursing
- childbearing ability